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DISCRIMINATIVE STIMULUS EFFECTS OF
(+)-7-OH-DPAT IN RATS:IMPORTANCE
OF 0 3 RECEPTORS
April J. Christian, M.A.
Western Michigan University, 1999
Despite the reported relatively high binding affin
ity of 7-OH-DPAT to dopamine 0 3 receptors, results of re
cent investigations with the highly selective 0 3 receptor
antagonist, PNU-99194A have questioned the importance of
0 3 receptors in the discriminative stimulus effects of
7-OH-DPAT.

In the present study, sixteen male Sprague-

Dawley rats (N=8/group) were trained to discriminate (+)7-OH-DPAT (0.03 mg/kg, sc) from saline in a two-lever op
erant procedure using a fixed-ratio 20 schedule of water
reinforcement.

After stable performance was established,

substitution tests were conducted with the O 3 -prefering
agonist,

(+)-PD-128907 and the psychostimulant cocaine.

Additionally, antagonism were conducted with the selec
tive 0 2 antagonist, remoxipride.

Cocaine failed to pro-

duce generalization, but (+)-PD-128907 did substitute for
the (+)-7-OH-DPAT cue.

Remoxipride appeared to partially

block (+)-7-OH-DAPT discrimination.

Future investiga-

tions with highly selective D 3 antagonists are discussed.
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INTRODUCTION
Recent investigations of the behavioral pharmacology
of addictive psychostimulant drugs have focused on_ the
dopamine (DA) 0 3 receptor subtype,

(Bevins, Klebaur, &

Bardo, 1997; Caine & Koob, 1995; Lamas, Negus, Nader, &
Mello, 1996; Spealman, 1996) a subdivision of the 0 2 fam
ily of dopamine receptors (Civelli et al., 1991; Sibley &
Monsma, 1992).

This receptor subtype is localized in

limbic regions of the brain (Levesque et al., 1992),
areas well known to be involved in the reinforcing and
discriminative stimulus properties of the psychostimulant
drugs.

Increased understanding of the role of 0 3 recep-

tors in mediating the behavioral effects of psychostimu
lants may benefit the development of pharmacological
treatment interventions for psychostimulant abuse, as
well as central nervous system (CNS) diseases.

However,

investigations on the importance of 0 3 receptor mediation
of psychostimulant drug actions are limited due to the
lack of highly selective 0 3 receptor ligands.
Despite the fact that compounds with clear selectiv
ity for 0 3 receptors have not become generally available,
it has been shown that several dopamine agonists, some of
1
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which had previously been considered highly selective for
D2 receptors, have a relatively high affinity for D 3 re
ceptors (Burris et al., 1995; DeMattos et al., 1993;
Levesque et al., 1992; Pugsley et al., 1995).

Compounds

such as 7-OH-DPAT (7-hydroxy-N,N-di-n-propyl-2-amino
tetralin) and (+)-PD-128907 have been reported to have as
much as a 100-fold greater affinity for D 3 over D 2 recep
tors based on in vitro binding assays (Burris et al.,
1995; OeMattos et al., 1993; Levesque et al., 1992; Pugsley et al., 1995).

Therefore, these compounds along

with other compounds with moderate selectivity for 0 3 re
ceptors, are currently used to analyze 0 3 receptor func
tion (Levesque et al., 1992; Pugsley et al., 1995).
7-OH-OPAT and PNU-99194A, a highly selective 0 3 receptor
antagonist, have been used to investigate the role of 0 3
receptors in the reinforcing and discriminative stimulus
properties of psychomotor stimulants.
Several investigations have shown either complete or
partial generalization to 7-OH-OPAT and other putative 0 3
agonists in animals trained to discriminate cocaine (Acri
et al., 1995; Lamas et al., 1996; Spealman, 1996) or d
amphetamine (Baker, Svensson, Garner, & Goodwin, 1998;
Bevins et al., 1996).

However, results of recent inves

tigations by Baker et al. ( 1998) and Garner and Baker

(1999), question the importance of the D 3 receptor media
tion of the discriminative stimulus effects of (+)-7-0H
DPAT.

Results from these studies revealed that PNU-

99194A failed to block the stimulus generalization pro
duced by (+)-7-0H-DPAT in rats trained to discriminate
d-amphetamine or cocaine.
Results from studies by McElroy (1994), Sanger et
al.

(1997), and Varty and Higgins (1997) have demon

strated that the racemic form of this compound acquires
stimulus control in rats.
al.

An investigation by Sautel et

(1995) gives indirect evidence for the D 3 receptor

mediation of the discriminative stimulus effects of
7-0H-DPAT.

The potencies of cue substitution by several

dopamine agonists were more strongly correlated with D 3
than D 2 in vitro potencies (Sanger, & Depoortere, 1997).
A study by Varty and Higgins (1997) supports results of
Sanger and Depoortere (1997) with evidence for D 3 recep
tor mediation of the discriminative stimulus effects of
7-0H-DPAT.

Data suggest that the pharmacological profile

of the various dopaminergic drugs to generalize to the
7-0H-DPAT cue was most consistent with D 3, rather than D 2
receptor interaction.

However, these conclusions are

based on the use of D 2 and D 3 agonists, and the racemic
form of 7-0H-DPAT.

Reports have suggested that the (+)-

3

enantiomer is the more active (Wikstrom et al., 1985) and
exhibits a higher 0 3 affinity (Baldessarini et al., 1993;
0amsma et al., 1993).

Therefore, investigations with the

(+)-enantiomer, and 0 3 and 0 2 antagonists, it may be pos
sible to determine whether 0 3 or 0 2 receptors modulate
(+)-7-0H-0PAT's discriminative stimulus effects.
The establishment of (+)-7-0H-0PAT as the discrimi
native cue has helped to accelerate assessment of 0 3 re
ceptor involvement in the discriminative stimulus proper
ties of psychostimulants (Baker et al., in press). Re
sults from this investigation showed that the discrimina
tive stimulus effects of (+)-7-0H-0PAT were not blocked
by the highly selective 0 3 antagonist, PNU-99194A.
findings are consistent with Baker et al.
ner and Baker (1998).

These

(1998) and Gar-

Results from Garner and Baker

(1999) indicate that remoxipride, a selective 0 2 antago
nist, blocks (+)-7-0H-0PAT substitution for cocaine at
doses that appear to reverse the response rate suppres
sion.

Antagonism tests with highly selective 0 3 antago

nists, such as PNU-99194A, and 0 2 antagonists, such as
remoxipride could determine the contribution of 0 3 versus
0 2 receptor mediation of 7-0H-0PAT's discriminative
stimulus effects.
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The primary goal of the present study was to assess
the antagonism of (+)-7-OH-DPAT by the D 2 antagonist, remoxipride.

Baker et al.

(in press) investigated the (+)-

enantiomer of 7-OH-DPAT as a training cue in drug dis
crimination.

To extend previous findings, the present

study assessed D 3 receptor mediation of (+)-7-OH-DPAT
discrimination by training animals to discriminate this
compound from saline and testing for antagonism with re
moxipride.

Additionally, stimulus generalization was as

sessed with a highly selective D 3 agonist,

(+)-PD-128907,

and with cocaine, a nonselective dopamine agonist.
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METHOD
Subjects
Sixteen male Sprague-Dawley rats (Harlan Breeding
Laboratories, Indianapolis, IN) aged approximately two
months and weighing approximately 225-250g at the begin
ning of the study served as subjects.

The animals had no

previous operant training and were drug naive at the beginning of the present experiment.

The rats were housed

individually in plastic cages, in a colony maintained on
a 12hr light:dark cycle (07:00-19:00hr) and at a relatively constant temperature (19-23°C) and humidity
(62-77%).

Commercial rat feed was freely available and

water was restricted to amounts received during 20 min
training sessions and an additional 30 minutes per day.
Free access to water was given for 24 hours approximately
every seven days.

The animals were maintained in accor-

dance with the general principles of animal husbandry
outlined by the National Institutes of Health, and the
experimental protocol was reviewed and approved by the
Institutional Animal Care and Use Committee (IACUC) of
Western Michigan University (Appendix A).
6
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Apparatus
Training and testing sessions were conducted in
eight standard operant chambers (ENV-001; MED Associates
Inc., St. Albans, VT), housed in sound and light attenu
ating shells equipped with fans to provide ventilation
and masking noise.

Each chamber contained an overhead

28V house light and a liquid reinforcer delivery mecha
nism (0.1 ml) that was mounted equidistant between two
removable levers on the front panel of the chamber.

A

center removable lever was located between those two lev
ers and used only during the initial auto-shaping ses
sions.

A Zenith 320-SX microcomputer programmed with MED

Associates Inc., St. Albans, VT; version 2.0) was used to
control experimental events and data collection.
Drugs
(+)Pharmacia & Upjohn generously provided (+)-7-OHDPAT-hydrobromide, and remoxipride-hydrochloride.

(+) -

PD-128907-hydrochloride was purchased from Research Bio
chemicals International (Natick, MA).

National Institute

on Drug Abuse (Bethesda, MD) provided cocaine
hydrochloride.

All drugs were dissolved in bacterio

static 0.9% saline.

All drugs were administered by sub

cutaneous (sc) injection, except cocaine hydrochloride,

which was administered by intraperitoneal (ip) injection.
All doses of each drug were calculated based on the salt.
Errorless Training Procedure
Prior to discrimination training, rats (N = 8/group)
were auto-shaped to lever press on.the center lever under
a schedule of continuous water reinforcement.

No injec

tions were given prior to these sessions. Once lever
pressing was established, injections of either (+)-7-OHDPAT (0.03 mg/kg) or saline (0.9% NaCl) were given.

Drug

or saline was administered subcutaneously 15 minutes
prior to daily (Monday-Saturday) sessions.

Training be

gan under a fixed-ratio 1 (FRl) schedule of water rein
forcement with only the stimulus-appropriate (drug or
saline) lever present.

Half of the animals were rein

forced with water (0.1 ml) for left-lever responses fol
lowing saline; conditions were reversed for remaining
animals.
tion.

Three sessions were conducted under each condi-

During training, neither condition (drug or

saline) prevailed for more than two consecutive (20 min)
sessions. Levers were wiped with isopropyl alcohol before
each session to reduce the influence of olfactory stimuli
on lever pressing (Extance & Goudie, 1981).

8
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Discrimination Training Procedure
Discrimination training began on the seventh training session, with both levers present.

Injections of

either (+)-7-OH-DPAT (0.03 mg/kg) or saline (0.9% NaCl)
were given.

Drug or saline was administered subcutane-

ously 15 minutes prior to daily sessions.

Half of the

animals were reinforced with water (0.1 ml) for left
lever responses following saline; conditions were reversed for remaining animals.

Levers were wiped with

isopropyl alcohol before each session to reduce the in
fluence of olfactory stimuli on lever pressing (Extance &
Goudie, 1981).

During training, injections were given in

a pseudo-random order and neither condition (drug or sa
line) prevailed for more than two consecutive (20 min)
sessions.

The schedule of reinforcement was increased

until all animals were responding reliably under a fixed
ratio 20 schedule of water reinforcement (FR 20) for each
experimental condition.

In addition, the two groups of

animals were frequently run in different orders.

The

criterion for discrimination was a minimum of 80% condi
tion-appropriate lever selection prior to the delivery of
the first reinforcer for nine out of ten consecutive
training sessions.

Testing Procedure
Tests for antagonism and stimulus generalization
tests were given after the aforementioned criteria were
met.

Test sessions were conducted in a similar manner to

training sessions with the exception that no reinforcers
were delivered and the animal was removed from the cham
ber upon completion of 20 consecutive responses on either
lever, or when 20 minutes elapsed, whichever occurred
first.

For tests of antagonism, remoxipride was given 30

minutes prior to the testing session, followed with the
respective (+)-7-OH-DPAT dose 15 minutes prior to testing.

For each drug tested the order of doses was coun-

terbalanced among subjects, and approximately half the
animals received tests after drug maintenance sessions
while the other half received tests after saline maintenance sessions.

Subjects were administered at least two

training sessions between test sessions and were required
to maintain the 80% criterion under both training condi
tions before each test.

A dose-response curve was deter

mined with all 16 subjects (0.0, 0.003, 0.01, 0.03, and
0.10 mg/kg).

A subgroup of these animals were adminis

tered stimulus generalization tests with several doses of
(+)-PD-128907 (0.0, 0.01, 0.03, 0.10, and 0.30 mg/kg;
n = B) and cocaine (0.0, 1.5, 2.5, 5.0, and 10 mg/kg; n = B)
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Another subgroup was administered antagonism tests with
remoxipride (3.0 and 10.0 mg/kg; n= 8) in combination with
each of several doses of (+)-7-OH-DPAT (0.0, 0.01, 0.03,
and 0.10 mg/kg).
Data Analysis
Dose response data were presented as the percent of
total responses made on the drug-appropriate lever during
test sessions.

Response rate was presented as the number

of responses made (on either lever) per second during
test sessions.

For each dose tested, the mean and stan-

dard error of the mean were calculated for each of these
dependent measures.

In the event that an animal did not

complete at least 15 total responses during a test ses
sion, the percentage of drug-lever appropriate responses
for that test was not included in the statistical analyses.

Drug-lever selection that was 80% or greater was

considered evidence for stimulus generalization.

Com

plete antagonism was defined as drug-appropriate responding less than 20%.

Drug appropriate responding between

20% and 80% was considered evidence for partial substitution or partial antagonism.

Dose response curves were

also analyzed using a nonlinear regression, and ED 50 's and
confidence intervals were calculated.

A one-way analysis

11

of variance (ANOVA) was also conducted on the effects of
(+)-7-OH-DPAT (0.0, 0.003, 0.01 and 0.03 mg/kg), (+)-PD128907 (0.0, 0.01, 0.03,0.10, and 0.30 mg/kg), and
cocaine hydrochloride (0.0, 1.5, 2.5, 5.0, and 10.0
mg/kg) on percent and rates of lever pressing.

In the

event that the dependent variables were significant, a
Tukey's post hoc test was employed to determine were the
significant differences were.

Statistical analyses were

conducted using the software GraphPad Prism (Version 2.0;
GraphPad, Inc., San Diego, CA).
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RESULTS
Acquisition and (+)-7-OH-DPAT Discrimination
All rats acquired the (+)-7-OH-DPAT discrimination.
Eight of the 16 rats met the discrimination criterion of
at least 80% correct responding prior to the first rein
forcer for 10 consecutive sessions, and the remaining
eight rats met the criterion in nine out of 10 consecu
tive sessions.

The mean number of sessions to criterion

for the sixteen rats was 34 (S.E.M. = 11.75; Range: 2263; Median

=

28).

Figure 1 illustrates the (+)-7-OH-DPAT dose-response
curve (n

=

16).

This compound dose-dependently increased

percentage of drug-appropriate responding, with full sub
stitution following 0.03 and 0.10 mg/kg, and partial sub
stitution following 0.01 mg/kg.

The ED 50 was 0.01 mg/kg

(95% confidence intervals: 0.008-0.012 mg/kg).

The per

cent drug-appropriate responding following doses of 0.03
and 0.10 mg/kg was significantly different from saline
(F 3 ,6 3 = 61.27, p < 0.0001).

This compound also signifi

cantly decreased response rate in a dose-dependent manner
(F 3 ,6 3 = 6.27, p = 0.0012).

Response rate was signifi13
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cantly different from saline following the 0.10 mg/kg
dose(p < 0.01).
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Substitution Tests
(+)-PD-128907, a highly selective D 3 agonist, sub
stituted fully for (+)-7-OH-DPAT at a dose of 0.30 mg/kg,
with an ED 50 of 0.08 mg/kg (95% confidence interval
0.04-0.14; Figure 2, top; n

=

=

8). . Partial generalization

of (+)-PD-128907 occurred at a dose of 0.10 mg/kg.

There

was no substitution at doses of 0.01 and 0.03 mg/kg (+)
PD-128907.

A repeated-measures ANOVA showed a signifi

cant effect of (+)-PD-128907 on percent drug-lever re
sponding (F 4,39 = 24.86, p < 0.0001).

Percent drug-lever

responding following 0.0 mg/kg was significantly differ
ent from that following 0.10 mg/kg (p < 0.001) and 0.30
mg/kg (p < 0.001).

Response rate was also significantly

decreased by (+)-PD-128907 in a dose-dependent manner
(F 4, 39 = 6.022, p = 0.0013).

However, only the dose of

0.30 mg/kg produced a significant difference from saline
(p < 0.05).
The bottom of Figure 2 illustrates the results of
tests administered with cocaine (n= 8).

There was partial

generalization at doses of 1.5 and 10.0 mg/kg.

The ef

fect of cocaine on percent drug-lever responding was not
statistically significant.

Response rate was decreased
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by cocaine, but this effect was not statistically sig
nificant.
Antagonism Tests
Figure 3 illustrates the results of tests adminis
tered with remoxipride (0.0, 3.0, and 10.0 mg/kg) in com
bination with (+)-7-OH-DPAT (0.0, 0.01, 0.03, and 0.10
mg/kg; n= 8).

Pretreatment with this selective D2 antago

nist shifted the (+)-7-OH-DPAT dose-response curve to the
right, showing partial antagonism of (+)-7-OH-DPAT dis
crimination.

The ED50 of (+)-7-OH-DPAT alone was 0.01

mg/kg (95% confidence intervals

=

0.01-0.05 mg/kg).

When

administered in combination with 3.0 mg/kg remoxipride,
the ED50 of (+)-7-OH-DPAT was 0.03 mg/kg (95% confidence
intervals

=

0.01-0.24 mg/kg).

Following 10.0 mg/kg re

moxipride, the ED50 of (+)-7-OH-DPAT was 0.06 (95% confi
dence intervals

=

0.01-0.12 mg/kg).

The training dose of

(+)-7-OH-DPAT was not completely blocked by either dose
of remoxipride.

As stated above,

(+)-7-OH-DPAT dose

dependently decreased response rate.

Remoxipride ap

peared to attenuate the response rate reduction produced
by 0.10 mg/kg (+)-7-OH-DPAT, but this effect was not sta
tistically significant.

17

18
REMOXIPRIDE + (+)-7-0H-DPAT
100
Remoxipride Dose
80 -a-o.o mg/kg
-{J-3. 0 mg/kg
-0-10.0 mg/kg

-/,/ 1-v

60

40

,

/,1

;,,'

1,l
/,'
,

✓

20

0

g
0.0

/,'
�, ,,,'
0.01

0.03

0.10

1.5

0

�

u
Cl)

�

1

ff

1

Cl)

Cl)

�

I

Remoxipride Dose
-a-o.0 mg/kg
-0-3.0 mg/kg
-0·10.0 mg/kg

.5

.,,

.,,"

.,,

_l

�---o
0
0.0

0.01

0.03

0.10

DOSE OF (+)-7-OH-DPAT (mg/kg)

Figure 3.

Results of Combination (Antagonism) Tests With
DA D 2 Receptor Antagonist Remoxipride Co
administered With (+)-7-0H-DPAT.

DISCUSSION
The results of the present study support previous
findings that 7-OH-DPAT or the (+)-isomer of this com
pound readily establishes stimulus· control in rats (Baker
et al., in press; McElroy, 1994; Sanger & Depoortere,
1997; Varty & Higgins, 1997).

Previous studies have in

dicated a potential modulatory role of the D 3 receptor
subtype in the stimulus effects of 7-OH-DPAT (Bevins et
al., 1997; Sanger & Depoortere, 1997; Varty & Higgins,
1997).

Bevins et al. (1997) reported a rightward shift

in the 7-OH-DPAT dose-response curve with eticlopride
pre-treatment (0.01, 0.05 mg/kg).

However, because

eticlopride is a D2 /D 3 antagonist, these results did not
clearly distinguish the relative importance of D 3 versus
D2 receptors in the substitution of 7-OH-DPAT for d
amphetamine.

Moreover, recent results from our labora

tory have indicated that the discriminative stimulus ef
fects of (+)-7-OH-DPAT may be mediated by 0 2 receptors.
For example, the highly selective 0 2 agonist, PNU-91356A,
produces complete generalization in animals trained to
discriminate (+)-7-OH-DPAT (Baker et al., in press).

Re

sults of the present study demonstrated complete stimulus
19

generalization with a D3 -preferring agonist,
128907.

(+)-PD-

Given these results, the question still remains

regarding the importance of D2 versus D3 receptor media
tion of the discriminative stimulus effects of (+)-7-OH
DPAT.
The determination of the relative importance of D3
receptors in mediating the discriminative stimulus ef
fects of (+)-7-OH-DPAT requires tests with highly selec
tive D3 and D2 antagonists in combination with the train
ing stimulus.
able.

Recently such compounds have become avail

The present study documents that the discrimina

tive cue associated with (+)-7-OH-DPAT (0.03 mg/kg) is
only partially blocked by the highly selective D2 antago
nist, remoxipride.

The rightward shift in the dose

response curve (Figure 3) suggests partial attenuation of
the (+)-7-OH-DPAT discriminative stimulus cue.

Specifi

cally, the ED50 of (+)-7-OH-DPAT shifted from 0.01 mg/kg
to 0.03 mg/kg when administered in combination with re
moxipride.

However, the 95% confidence intervals of each

ED50 value overlapped.

Moreover, discrimination of the

training dose was only partially attenuated by either
dose of remoxipride.

These data support preliminary re

sults of Baker et al. (in press) that reported partial
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blockade of the (+)-7-OH-DPAT cue by remoxipride 3.0
mg/kg.
Preliminary data from our laboratory also indicate
only partial antagonism of the (+)-7-OH-DPAT (0.03 mg/kg)
cue by PNU-99194A (10.0 mg/kg).

These data are consis

tent with previous results from Baker et al.

(in press)

that PNU-99194A does not block the discriminative stimu
lus effects of (+)-7-OH-DPAT.

These results are also

consistent with results that PNU-99194A does not block
stimulus generalization produced by (+)-7-OH-DPAT in rats
trained to discriminate d-amphetamine or cocaine (Baker
et al., 1998; Garner & Baker, 1999).

Thus, it appears

that D 3 receptors are not selectively involved in the
discriminative stimulus effects of (+)-7-OH-DPAT.
While the importance of D3 versus D2 receptor media
tion of the (+)-7-OH-DPAT cue remains unclear, it is at
least clear that the discrimination of this compound is
not based on a general dopamine cue, because cocaine, a
dopamine re-uptake inhibitor, failed to produce generali
zation.

None of the doses tested (1.5 - 10.0 mg/kg) pro

duced more than 30% drug-appropriate responding.
In summary, recent research using moderately selec
tive D 3 receptor ligands have led to tentative conclu
sions regarding the involvement of this receptor subtype
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in the behavioral actions of psychostimulant drugs.
Clinical implications of this research are considerably
important.

Pharmacological and behavioral research of

the D 3 receptor subtype may strongly impact the develop
ment of more effective treatments for CNS diseases, such
as Parkinson's Disease, schizophrenia, and psychostimulant addiction.

Results of recent studies, using 7-0H-

DPAT and similar compounds should be considered dili
gently until more selective ligands become readily avail
able for investigation.

The drug discrimination assay is

a usual tool for determining involvement of receptor sub
types underlying the discriminative stimulus effects of
various compounds.

Using this procedure, the present

study demonstrated that the (+)-7-0H-DPAT cue appears to
be specific, and may or may not be mediated selectively
by a D2 or D 3 -mediated cue.

Further investigations are

needed to determine the relative importance of D 3 recep
tor mediation of (+)-7-0H-DPAT's discriminative stimulus
effects.

Experiments involving pre-treatment with the

combination of D2 and D 3 selective antagonists are
planned.

The results of these experiments could acceler-

ate our knowledge of the importance of D2 and D 3 receptor
mediation of (+)-7-0H-DPAT discrimination.
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Appendix A
Protocol Clearance From the Institutional Animal
Care and Use Committee (IACUC)
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